Methods for assessing quality of life in the cardiac arrhythmia suppression trial (CAST).

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 1301128)

Published in Qual Life Res on June 01, 1992

Authors

I Willund1, L Gorkin, Y Pawitan, E Schron, J Schoenberger, L L Jared, S Shumaker

Author Affiliations

1: Department of Medicine, University of Göteborg, Ostra Hospital, Sweden.

Associated clinical trials:

Cardiac Arrhythmia Suppression Trial (CAST) | NCT00000526

Articles by these authors

A randomized trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. The Fitness Arthritis and Seniors Trial (FAST). JAMA (1997) 6.55

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene (2007) 5.79

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group. Lancet (1999) 3.81

The relationship of education to blood pressure: findings on 40,000 employed Chicagoans. Circulation (1976) 2.64

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med (1997) 2.40

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11

Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ (1995) 2.10

Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol (1999) 1.76

Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Arch Intern Med (1996) 1.72

Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol (1998) 1.70

Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol (1996) 1.64

Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer. Oncogene (2012) 1.62

Maintenance of dietary behavior change. Health Psychol (2000) 1.55

Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke (1997) 1.54

Association between ease of suppression of ventricular arrhythmia and survival. Circulation (1995) 1.48

Modeling mortality fluctuations in Los Angeles as functions of pollution and weather effects. Environ Res (1988) 1.44

Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 1.35

A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35

Long-term effects on plasma lipids of diet and drugs to treat hypertension. Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA (1996) 1.33

The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J (2000) 1.33

The evaluation of pain in patients with knee osteoarthritis: the knee pain scale. J Rheumatol (1995) 1.32

Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Control Clin Trials (2000) 1.27

Self-efficacy and pain in disability with osteoarthritis of the knee. J Gerontol B Psychol Sci Soc Sci (1996) 1.13

Enrollment in clinical trials: institutional factors affecting enrollment in the cardiac arrhythmia suppression trial (CAST). Control Clin Trials (1992) 1.11

A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry (2012) 1.09

Psychosocial predictors of mortality in the Cardiac Arrhythmia Suppression Trial-1 (CAST-1). Am J Cardiol (1993) 1.04

Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol (1991) 1.03

The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups. Prev Med (1981) 1.03

Depressive symptomatology in coronary artery bypass graft surgery patients. Int J Geriatr Psychiatry (1999) 1.03

Multicomponent variance estimation for binary traits in family-based studies. Genet Epidemiol (2006) 1.02

Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): a reexamination. Am J Crit Care (1997) 1.02

Low-dose aspirin use and cancer characteristics: a population-based cohort study. Br J Cancer (2013) 0.99

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators. J Am Coll Cardiol (1994) 0.98

Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators. Am J Cardiol (1991) 0.96

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. J Am Coll Cardiol (1999) 0.93

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators. Am Heart J (1996) 0.92

Children and adults with acute lymphoblastic leukaemia have similar gene expression profiles. Eur J Haematol (2005) 0.90

Lipid and lipoprotein responses to episodic occupational and academic stress. Arch Intern Med (1991) 0.90

Estimation of genetic and environmental factors for melanoma onset using population-based family data. Stat Med (2006) 0.88

Knee osteoarthritis and health-related quality of life. Med Sci Sports Exerc (1994) 0.88

Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis. Antimicrob Agents Chemother (1995) 0.87

Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry. J Am Coll Cardiol (1991) 0.87

Determinants of perceived health in patients with left ventricular dysfunction: a structural modeling analysis. Psychosom Med (1997) 0.86

Reducing negativity artifacts in emission tomography: post-processing filtered backprojection solutions. IEEE Trans Med Imaging (1993) 0.86

Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients. J Am Coll Cardiol (1991) 0.85

Identification of a secondary peak in myocardial infarction onset 11 to 12 hours after awakening: the Cardiac Arrhythmia Suppression Trial (CAST) experience. J Am Coll Cardiol (1993) 0.84

Data monitoring in the cardiac arrhythmia suppression trial. Online J Curr Clin Trials (1993) 0.83

Atrial fibrillation: a risk factor for increased mortality--an AVID registry analysis. J Interv Card Electrophysiol (2001) 0.82

Relation of psychosocial and stress reactivity variables to ventricular arrhythmias in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol (1990) 0.81

Diagnostic and therapeutic use of membrane proteins in cancer cells. Curr Med Chem (2011) 0.81

Quality of life post-myocardial infarction: effects of a transtelephonic coronary intervention system. Health Psychol (1988) 0.81

Psychological distress as a predictor of ventricular arrhythmias in a post-myocardial infarction population. Am Heart J (1988) 0.81

Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database. Circulation (1999) 0.80

Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee. Diabetes Care (2000) 0.80

Treatment of sudden cardiac death. Current understandings from randomized trials and future research directions. Circulation (1997) 0.80

Gene profile and response to treatment. Ann Oncol (2005) 0.78

Thermography - a valuable tool to test hydrocephalus shunt patency. Acta Neurochir (Wien) (2005) 0.78

Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients. Am J Transplant (2011) 0.78

Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients. Qual Life Res (1998) 0.77

Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients. Qual Life Res (1998) 0.76

Effects of advancing age on the efficacy and side effects of antiarrhythmic drugs in post-myocardial infarction patients with ventricular arrhythmias. The CAST Investigators. J Am Geriatr Soc (1992) 0.75

The relationship of work pace to back injury in a supermarket distribution center. J Occup Rehabil (1992) 0.75

Systolic Hypertension in the Elderly Program (SHEP). Part 3: Sociodemographic characteristics. Hypertension (1991) 0.75

Baseline characteristics of the PEPI participants. Postmenopausal Estrogen/Progestin Interventions. Control Clin Trials (1995) 0.75

The effects of a transtelephonic surveillance and prehospital emergency intervention system on the 1-year course following acute myocardial infarction. Am Heart J (1988) 0.75

Cardiovascular risk factor reduction in the workplace: why and how? Occup Health Nurs (1985) 0.75

Relationship between rehospitalization and future death in patients treated for potentially lethal arrhythmia. J Cardiovasc Electrophysiol (2001) 0.75

Relation of sociodemographic, clinical, and quality-of-life variables to adherence in the cardiac arrhythmia suppression trial. Cardiovasc Nurs (1996) 0.75

Characteristics of participants at baseline in the Treatment of Mild Hypertension Study (TOMHS). Am J Cardiol (1990) 0.75

Immediate excision of burn wounds. Am Surg (1978) 0.75

Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective. Drug Saf (1991) 0.75

The relationship between post-load plasma glucose and blood pressure at different resting heart rates. J Chronic Dis (1979) 0.75

Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension. Clin Ther (1986) 0.75

Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis. Clin Ther (1996) 0.75

Young adults at risk for hypertension: effects of family history and anger management in determining responses to interpersonal conflict. J Psychosom Res (1983) 0.75

Celiprolol in systemic hypertension. Am J Cardiol (1989) 0.75

Estimating the number of true discoveries in genome-wide association studies. Stat Med (2011) 0.75

The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice. Am J Crit Care (1996) 0.75

Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertension. Am J Cardiol (1992) 0.75

Moricizine and quality of life in the Cardiac Arrhythmia Suppression Trial II (CAST II). Control Clin Trials (1994) 0.75